Comorbidity Prevalence and Impact on Quality of Life in Gay and Bisexual Men Following Prostate Cancer Treatment.
Bisexual Men
EPIC
Gay Men
Health Related Quality of Life
Homosexual Men
Prostate Cancer
SF12
Journal
Sexual medicine
ISSN: 2050-1161
Titre abrégé: Sex Med
Pays: England
ID NLM: 101631053
Informations de publication
Date de publication:
Dec 2021
Dec 2021
Historique:
received:
10
05
2021
revised:
24
08
2021
accepted:
30
08
2021
pubmed:
12
10
2021
medline:
12
10
2021
entrez:
11
10
2021
Statut:
ppublish
Résumé
Studies have demonstrated worse health related quality of life (HRQOL) outcomes in gay and bisexual men (GBM) following prostate cancer treatment compared to heterosexual men potentially due to differences in comorbidity burden. To establish the prevalence of comorbidities and their association with HRQOL metrics in GBM following prostate cancer treatment. We evaluated HRQOL and prevalence of comorbidities in 193 GBM from the United States and Canada in a cross-sectional, online survey: the Masked for Review. HRQOL was measured with the Expanded Prostate Cancer Index Composite (EPIC) and the 12-Item Short Form Health Survey (SF-12). Our outcomes included comorbidity prevalence, mean differences for HRQOL scores by comorbidity status, and mean differences for HRQOL by comorbidity count. GBM were found to have a higher prevalence of blood vessel disease and mental health disorders but lower prevalence of obesity and type 2 diabetes when compared to published data in general prostate cancer populations. Statistically significant reductions in HRQOL metrics were associated with mental health diagnoses, diabetes, and obesity. Increased number of comorbidities was also associated with reductions in HRQOL metrics in nearly all categories. These results suggest that the worse QOL outcomes in GBM following prostate cancer treatment may be due to differences in comorbidity burden. This study is the first to evaluate the relationship between comorbidities and HRQOL outcomes in GBM. Limitations of this study include a small sample size and cross-sectional study design. If confirmed in larger, longitudinal, clinically confirmed studies, these findings indicate a need to intervene on and consider comorbidities in GBM diagnosed with prostate cancer. Haggart R, Polter E, Ross M, et al. Comorbidity Prevalence and Impact on Quality of Life in Gay and Bisexual Men Following Prostate Cancer Treatment. Sex Med 2021;9:100439.
Identifiants
pubmed: 34634579
pii: S2050-1161(21)00119-7
doi: 10.1016/j.esxm.2021.100439
pmc: PMC8766256
pii:
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100439Subventions
Organisme : NCI NIH HHS
ID : R21 CA182041
Pays : United States
Informations de copyright
Copyright © 2021 International Society for Sexual Medicine. Published by Elsevier Inc. All rights reserved.
Références
Lancet Glob Health. 2017 Nov;5(11):e1133-e1141
pubmed: 28964756
Med Care. 1996 Mar;34(3):220-33
pubmed: 8628042
Knee Surg Sports Traumatol Arthrosc. 2014 Aug;22(8):1933-9
pubmed: 24253376
Urology. 2015 Jan;85(1):101-5
pubmed: 25530370
Urology. 2013 Sep;82(3):565-71
pubmed: 23768520
Eur Urol. 2017 Oct;72(4):521-531
pubmed: 28089304
BJU Int. 2013 Jul;112(2):E67-75
pubmed: 23795800
Urology. 2010 Sep;76(3):553-7
pubmed: 20627284
Can J Urol. 2013 Apr;20(2):6702-6
pubmed: 23587510
Sex Med. 2014 Aug;2(3):115-20
pubmed: 25356308
Am J Public Health. 2007 Nov;97(11):2048-55
pubmed: 17463371
Diabetes Educ. 2018 Feb;44(1):83-93
pubmed: 29298611
Nat Rev Urol. 2014 Jun;11(6):317-23
pubmed: 24818853
J Sex Med. 2016 Mar;13(3):425-34
pubmed: 26853048
Psychooncology. 2017 Oct;26(10):1576-1585
pubmed: 27943512
BJU Int. 2011 Jul;108(1):110-5
pubmed: 20955264
J Sex Med. 2014 Sep;11(9):2308-17
pubmed: 24888965
J Community Health. 2013 Jun;38(3):588-96
pubmed: 23397511
Medicine (Baltimore). 2018 Oct;97(42):e12766
pubmed: 30334964
Eur Urol. 2013 Apr;63(4):693-701
pubmed: 22959192
JCO Clin Cancer Inform. 2018 Dec;2:1-10
pubmed: 30652570
JAMA Oncol. 2019 Sep 1;5(9):e191742
pubmed: 31369037
Qual Life Res. 2008 Aug;17(6):845-55
pubmed: 18506598
BMJ Open. 2014 Mar 13;4(3):e003901
pubmed: 24625637
J Sex Med. 2013 Aug;10(8):2094-100
pubmed: 23742184
Cancer. 2005 Jul 1;104(1):191-8
pubmed: 15912494
Urology. 2000 Dec 20;56(6):899-905
pubmed: 11113727
J Consult Clin Psychol. 2003 Feb;71(1):53-61
pubmed: 12602425
J Urol. 2018 Mar;199(3):683-690
pubmed: 29203269
BJU Int. 2011 Apr;107(8):1223-31
pubmed: 21070583
AIDS Behav. 2015 Oct;19(10):1928-37
pubmed: 25805443
Nat Clin Pract Urol. 2007 Nov;4(11):605-14
pubmed: 17982437
LGBT Health. 2015 Dec 24;3(1):49-56
pubmed: 26698658
Prostate Cancer Prostatic Dis. 2017 Mar;20(1):72-78
pubmed: 27698439